Cholesterol guidelines setback

Share this article:

Last week's news that new cholesterol guidelines were in place revved up industry chatter about what this could mean for the statin market. Yet a problem has surfaced: the calculator that would help doctors calculate patient risk is not working right.

The New York Times reports that the calculator “could mistakenly suggest that millions more people are candidates for statin drugs.” The NYT says the American Heart Association and American College of Cardiology are saying that although the calculator is not running as expected, the tool is a sign of progress.

The two groups developed the new guidelines which focus less on cholesterol levels and more on heart disease/stroke risk if a patient has already made lifestyle changes (read: diet and exercise). The risks, as noted by CNN, include factors such as whether a patient is diabetic, and/or has heart disease. The NYT notes that target levels will still be important for patients with high LDL levels.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.